Alzheimer’s Disease

Diabetes as a Risk Factor for Dementia

A new study published in the Internal Medicine Journal, examined the association of diabetes with the onset of dementia (including Alzheimer’s disease (AD), vascular dementia (VD) and any dementia) and mild cognitive impairment (MCI). A meta-analysis of longitudinal studies that examined the relationship between diabetes and the onset of dementia or MCI were included. Nineteen […]

Read More
DETAIL

Who Benefits the Most from Cognitive Stimulation Therapy for Dementia?

A study in the International Journal of Geriatric Psychiatry reports that the efficacy of cognitive stimulation therapy (CST) has been demonstrated, but little is known about the characteristics of people with dementia, who may respond to this therapy. This study sought to investigate which factors may predict a more positive response to CST. Subjects diagnosed […]

Read More
DETAIL

Alzheimer’s Biomarker and Major Depression

Research published in the American Journal of Psychiatry demonstrates that elderly patients who are cognitively intact and diagnosed with major depression may have low levels of amyloid beta 42 (Aß-42) in cerebral spinal fluid (CSF). Aß-42 has been implicated in Alzheimer’s disease as the main component of plaques. According to the authors, amyloid beta peptides […]

Read More
DETAIL

Cognitive Stimulation Beneficial in Dementia

According to a systematic review by Cochrane researchers, Cognitive stimulation therapies have beneficial effects on memory and thinking in people with dementia. Despite concerns that cognitive improvements may not be matched by improvements in quality of life, the review also found positive effects for well-being. There has, for some time, been a general belief that […]

Read More
DETAIL

Chair Summit Meeting Highlights – available now in HORM

Article series from the 3rd Annual Chair Summit, The Master Class for Neuroscience Professional Development (Chair Summit) available now in Health Outcomes Research in Medicine journal (HORM) The continuing professional development of clinicians protects one of our nation’s most precious human resources—a well-trained force of health care workers. Making decisions to manage illness and handle […]

Read More
DETAIL

Cerebrospinal Fluid Levels Change 5 to 10 Years Before the Onset of Alzheimer’s

According to a study in the Archives of General Psychiatry, approximately 90% of patients with MCI and pathologic CSF biomarker levels at baseline develop AD within 9 to 10 years. Levels of Aβ42 are already fully decreased at least 5 to 10 years before conversion to AD dementia, whereas T-tau and P-tau seem to be […]

Read More
DETAIL

New Clues About Memory Loss In Older People

New research published in Neurology links ‘silent strokes,’ found in one out of four older adults to memory loss in the elderly. A study of memory loss in the elderly examined both silent strokes and hippocampal shrinkage simultaneously. For the study, a group of 658 people ages 65 and older and free of dementia were […]

Read More
DETAIL

A New Brain Health App for Alzheimer’s Disease

The Bupa Health Foundation and Alzheimer’s Australia have announced the UK launch of a world-first brain health app, the latest digital tool to help in the fight against dementia. Based on latest research that links brain health and a reduced risk of dementia, to a healthy heart and cardiovascular system, ‘BrainyApp’ is the first dementia risk […]

Read More
DETAIL